EP1109887A4 - Production and use of dopaminergic cells to treat dopaminergic deficiencies - Google Patents
Production and use of dopaminergic cells to treat dopaminergic deficienciesInfo
- Publication number
- EP1109887A4 EP1109887A4 EP98959412A EP98959412A EP1109887A4 EP 1109887 A4 EP1109887 A4 EP 1109887A4 EP 98959412 A EP98959412 A EP 98959412A EP 98959412 A EP98959412 A EP 98959412A EP 1109887 A4 EP1109887 A4 EP 1109887A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- dopaminergic
- production
- treat
- deficiencies
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/24—Genital tract cells, non-germinal cells from gonads
- C12N2502/246—Cells of the male genital tract, non-germinal testis cells
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9451598P | 1998-07-29 | 1998-07-29 | |
US94515P | 1998-07-29 | ||
PCT/US1998/023977 WO2000006700A1 (en) | 1998-07-29 | 1998-11-10 | Production and use of dopaminergic cells to treat dopaminergic deficiencies |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1109887A1 EP1109887A1 (en) | 2001-06-27 |
EP1109887A4 true EP1109887A4 (en) | 2003-05-21 |
Family
ID=22245637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98959412A Withdrawn EP1109887A4 (en) | 1998-07-29 | 1998-11-10 | Production and use of dopaminergic cells to treat dopaminergic deficiencies |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1109887A4 (en) |
WO (1) | WO2000006700A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4573332B2 (en) | 2003-01-24 | 2010-11-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Lrp4 / Corin dopaminergic neuron proliferative progenitor cell marker |
EP1666590B1 (en) | 2004-07-22 | 2015-11-04 | Eisai R&D Management Co., Ltd. | Lrp4/corin dopamine-producing neuron precursor cell marker |
JP4926965B2 (en) | 2005-08-18 | 2012-05-09 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Dopaminergic neuron proliferative progenitor cell marker Nato3 |
EP2089512B1 (en) * | 2006-11-01 | 2014-11-26 | Rutgers, The State University of New Jersey | Lithium stimulation of cord blood stem cell proliferation and growth factor production |
EP2737057B1 (en) | 2011-07-27 | 2018-10-24 | Kyoto University | Novel markers for dopaminergic neuron progenitor cells |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990006757A1 (en) * | 1988-12-15 | 1990-06-28 | The Regents Of The University Of California | Grafting genetically modified cells to treat diseases of the central nervous system |
WO1994010292A1 (en) * | 1992-10-28 | 1994-05-11 | Neurospheres Ltd. | Biological factors and neural stem cells |
WO1996015224A1 (en) * | 1994-11-14 | 1996-05-23 | Neurospheres Holdings Ltd. | In vitro induction of dopaminergic cells |
WO1997033470A1 (en) * | 1996-03-12 | 1997-09-18 | University Of South Florida | Method and media for enhancing viability, maturation, and cryopreservation of cells |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175103A (en) * | 1991-10-21 | 1992-12-29 | Trustees Of University Of Pennsylvania | Preparation of pure cultures of post-mitotic human neurons |
-
1998
- 1998-11-10 WO PCT/US1998/023977 patent/WO2000006700A1/en not_active Application Discontinuation
- 1998-11-10 EP EP98959412A patent/EP1109887A4/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990006757A1 (en) * | 1988-12-15 | 1990-06-28 | The Regents Of The University Of California | Grafting genetically modified cells to treat diseases of the central nervous system |
WO1994010292A1 (en) * | 1992-10-28 | 1994-05-11 | Neurospheres Ltd. | Biological factors and neural stem cells |
WO1996015224A1 (en) * | 1994-11-14 | 1996-05-23 | Neurospheres Holdings Ltd. | In vitro induction of dopaminergic cells |
WO1997033470A1 (en) * | 1996-03-12 | 1997-09-18 | University Of South Florida | Method and media for enhancing viability, maturation, and cryopreservation of cells |
Non-Patent Citations (5)
Title |
---|
LAYTONBIO: "Press releases number: 24, 26, 27, 28, 29, 30, 31(a) to (k)", HTTP://WWW.LAYTONBIO.COM/WHATSNEW.HTM, 9 March 1999 (1999-03-09), XP002199748 * |
MENA MARIA ANGELES ET AL: "Effects of dibutyryl cyclic AMP and retinoic acid on the differentiation of dopamine neurons: Prevention of cell death by dibutyryl cyclic AMP.", JOURNAL OF NEUROCHEMISTRY, vol. 65, no. 6, 1995, pages 2612 - 2620, XP009001318, ISSN: 0022-3042 * |
PLEASURE S J ET AL: "PURE, POSTMITOTIC, POLARIZED HUMAN NEURONS DERIVED FROM NTERA 2 CELLS PROVIDE A SYSTEM FOR EXPRESSING EXOGENOUS PROTEINS IN TERMINALLY DIFFERENTIATED NEURONS", JOURNAL OF NEUROSCIENCE, NEW YORK, NY, US, vol. 12, no. 5, May 1992 (1992-05-01), pages 1802 - 1815, XP002915302, ISSN: 0270-6474 * |
See also references of WO0006700A1 * |
TERAO T ET AL: "LITHIUM CHLORIDE STIMULATES CATECHOLAMINE SYNTHESIS AND SECRETION IN CULTURED BOVINE ADRENAL MEDULLARY CELLS", BIOLOGICAL PSYCHIATRY, vol. 31, no. 10, 1992, pages 1038 - 1049, XP009001664, ISSN: 0006-3223 * |
Also Published As
Publication number | Publication date |
---|---|
EP1109887A1 (en) | 2001-06-27 |
WO2000006700A1 (en) | 2000-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5670047B1 (en) | Anaerobic treatment process for the rapid hydrolysis and conversion of organic materials to soluble and gaseous components | |
IL209596A0 (en) | Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues | |
PL335933A1 (en) | Highly permeable insert of improved collection and distribution power | |
IT1299162B1 (en) | PROSTHETIC ASSEMBLY TO BE USED IN SURGICAL THERAPY OF UROGENITAL PROLAPSE | |
HUP0202705A3 (en) | Methods and microorganisms or production of panto-compounds | |
AU5482599A (en) | Human mesencephalon cell lines and methods of use therefor | |
TJ347B (en) | Cryptophicin compounds pharmacentical composition method to inhibit the proliteration of cells and and method to treat neoplasia | |
GB9912159D0 (en) | Improvements in and relating to the treatment of water | |
AU2479099A (en) | Topical vasodilatory gel composition and methods of use and production | |
IL150125A0 (en) | Novel compounds | |
EP1109887A4 (en) | Production and use of dopaminergic cells to treat dopaminergic deficiencies | |
GB9814036D0 (en) | Materials and methods relating to the induction of apoptosis in target cells | |
ID18154A (en) | AMPLOP CAN BE USED EASY TO OPEN | |
PL327815A1 (en) | Fabric subject to treatment with cellulase and oxyrecuctase | |
AU2002251681A1 (en) | Production and use of dopaminergic cells to treat dopaminergic deficiencies | |
GB9912639D0 (en) | Improvements in and relating to treatment of respiratory conditions | |
ID17024A (en) | USE OF UVA BASED ON TRIAZIN, TO BE USED AS EXTINCTION IN PAPER MAKING PROCESS | |
EP0796322A4 (en) | Production and use of human and plant methyltransferases | |
GB9721075D0 (en) | Materials and methods relating to the stimulation of cells | |
GB2337153B (en) | Improvements in and relating to the collection of ions | |
GB9606415D0 (en) | Improvements in and relating to the generation of elecricity | |
AU5144299A (en) | Production and use of modified cystatins | |
SG87764A1 (en) | Methods of layering cache and architectural specific functions to expediate multiple designs | |
GB9621948D0 (en) | Improvements in and relating to the production of hydrogen | |
GB9622100D0 (en) | Improvements in and relating to the production of hydrogen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010226 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030402 |
|
17Q | First examination report despatched |
Effective date: 20040706 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060601 |